Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Epidermal powder immunization of mice and monkeys with an influenza vaccine.

Chen D, Endres R, Maa YF, Kensil CR, Whitaker-Dowling P, Trichel A, Youngner JS, Payne LG.

Vaccine. 2003 Jun 20;21(21-22):2830-6.

PMID:
12798624
2.

Promoting research integrity at the American Society for Microbiology.

Youngner JS.

Sci Eng Ethics. 2003 Apr;9(2):215-20.

PMID:
12774654
3.

Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials.

Townsend HG, Penner SJ, Watts TC, Cook A, Bogdan J, Haines DM, Griffin S, Chambers T, Holland RE, Whitaker-Dowling P, Youngner JS, Sebring RW.

Equine Vet J. 2001 Nov;33(7):637-43.

PMID:
11770983
4.

A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge.

Chambers TM, Holland RE, Tudor LR, Townsend HG, Cook A, Bogdan J, Lunn DP, Hussey S, Whitaker-Dowling P, Youngner JS, Sebring RW, Penner SJ, Stiegler GL.

Equine Vet J. 2001 Nov;33(7):630-6.

PMID:
11770982
5.

Derivation and characterization of a live attenuated equine influenza vaccine virus.

Youngner JS, Whitaker-Dowling P, Chambers TM, Rushlow KE, Sebring R.

Am J Vet Res. 2001 Aug;62(8):1290-4.

PMID:
11497453
6.

Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression.

Lunn DP, Hussey S, Sebing R, Rushlow KE, Radecki SV, Whitaker-Dowling P, Youngner JS, Chambers TM, Holland RE Jr, Horohov DW.

J Am Vet Med Assoc. 2001 Mar 15;218(6):900-6.

PMID:
11294315
7.

The scientific misconduct process: a scientist's view from the inside.

Youngner JS.

JAMA. 1998 Jan 7;279(1):62-4. No abstract available.

PMID:
9424047
8.

Dominance of cold-adapted influenza A virus over wild-type viruses is at the level of RNA synthesis.

Maloy ML, Whitaker-Dowling P, Youngner JS.

Virology. 1994 Nov 15;205(1):44-50.

PMID:
7975236
9.
10.
12.

Augmentation of natural killer cell activity in mice by Bru-Pel.

Yabu K, Youngner JS, Feingold DS, Keleti G, Gorelik E.

J Immunother (1991). 1991 Oct;10(5):307-12.

PMID:
1790138
13.

The genes associated with trans-dominance of the influenza A cold-adapted live virus vaccine.

Whitaker-Dowling P, Zvolenski R, Youngner JS.

Virology. 1991 Jan;180(1):81-7.

PMID:
1984670
14.

Cellular mechanisms in the superinfection exclusion of vesicular stomatitis virus.

Simon KO, Cardamone JJ Jr, Whitaker-Dowling PA, Youngner JS, Widnell CC.

Virology. 1990 Jul;177(1):375-9.

PMID:
2162110
15.

Sequential disassembly of the cytoskeleton in BHK21 cells infected with vesicular stomatitis virus.

Simon KO, Whitaker-Dowling PA, Youngner JS, Widnell CC.

Virology. 1990 Jul;177(1):289-97.

PMID:
2162105
16.
17.

Vaccinia specific kinase inhibitory factor prevents translational inhibition by double-stranded RNA in rabbit reticulocyte lysate.

Akkaraju GR, Whitaker-Dowling P, Youngner JS, Jagus R.

J Biol Chem. 1989 Jun 15;264(17):10321-5.

18.
19.

Characterization of a unique protein produced by influenza A virus recovered from a long-term persistent infection.

Lucas WT, Whitaker-Dowling P, Kaifer CR, Youngner JS.

Virology. 1988 Oct;166(2):620-3.

PMID:
2972115
20.
21.
22.

Viral interference-dominance of mutant viruses over wild-type virus in mixed infections.

Whitaker-Dowling P, Youngner JS.

Microbiol Rev. 1987 Jun;51(2):179-91. Review. No abstract available.

24.

The mechanism of the antiviral effect of interferon differs in two strains of a rabbit kidney cell line.

Whitaker-Dowling P, Kaifer C, Youngner JS.

J Interferon Res. 1987 Feb;7(1):61-8.

PMID:
2438358
25.
26.

Vaccinia-mediated rescue of encephalomyocarditis virus from the inhibitory effects of interferon.

Whitaker-Dowling P, Youngner JS.

Virology. 1986 Jul 15;152(1):50-7.

PMID:
2424172
27.

Interferon inhibits the growth of Legionella micdadei in mouse L cells.

Whitaker Dowling P, Dowling JN, Liu L, Youngner JS.

J Interferon Res. 1986 Apr;6(2):107-14.

PMID:
2425011
28.
29.

Persistent infection with influenza A virus: evolution of virus mutants.

Frielle DW, Huang DD, Youngner JS.

Virology. 1984 Oct 15;138(1):103-17.

PMID:
6388147
30.
31.
32.

Superinfection exclusion by vesicular stomatitis virus.

Whitaker-Dowling P, Youngner JS, Widnell CC, Wilcox DK.

Virology. 1983 Nov;131(1):137-43.

PMID:
6316647
33.
34.

Rapid inhibition of pinocytosis in baby hamster kidney (BHK-21) cells following infection with vesicular stomatitis virus.

Wilcox DK, Whitaker-Dowling PA, Youngner JS, Widnell CC.

J Cell Biol. 1983 Nov;97(5 Pt 1):1444-51.

35.

Interferon treatment inhibits pinocytosis.

Wilcox DK, Whitaker-Dowling PA, Youngner JS, Widnell CC.

Mol Cell Biol. 1983 Aug;3(8):1533-6.

36.

Interferon-mediated inhibition of virus penetration.

Whitaker-Dowling PA, Wilcox DK, Widnell CC, Youngner JS.

Proc Natl Acad Sci U S A. 1983 Feb;80(4):1083-6.

37.

Hydrocephalus in weanling mice induced by a temperature-sensitive mutant of vesicular stomatitis virus.

Ahdab-Barmada M, Moossy J, Preble OT, Youngner JS.

J Neuropathol Exp Neurol. 1982 Nov;41(6):606-17.

PMID:
6290612
39.

Varied responses of human B-lymphoblastoid cell lines to infection with vesicular stomatitis virus.

Creager RS, Whitaker-Dowling P, Frey TK, Youngner JS.

Virology. 1982 Sep;121(2):414-9. No abstract available.

PMID:
6289524
40.

Restriction of vesicular stomatitis virus in a nonpermissive rabbit cell line is at the level of protein synthesis.

Jones EV, Whitaker-Dowling PA, Youngner JS.

Virology. 1982 Aug;121(1):20-31. No abstract available.

PMID:
6287719
41.

Human lymphoblastoid cell lines of B- and T-cell origin: different responses to infection with vesicular stomatitis virus.

Creager RS, Cardamone JJ Jr, Youngner JS.

Virology. 1981 May;111(1):211-22. No abstract available.

PMID:
6165136
42.

Generation and amplification of temperature-sensitive mutants during serial undiluted passages of vesicular stomatitis virus.

Youngner JS, Jones EV, Kelly M, Frielle DW.

Virology. 1981 Jan 15;108(1):87-97. No abstract available.

PMID:
6267777
43.

Proposal for a uniform nomenclature for defective interfering viruses of vesicular stomatitis virus.

Reichmann ME, Bishop DH, Brown F, Crick J, Holland JJ, Kang CY, Lazzarini R, Moyer S, Perrault J, Prevec L, Pringle CR, Wagner RR, Youngner JS, Huang AS.

J Virol. 1980 Jun;34(3):792-4.

44.

Induction of interferon in L cells by defective-interfering (DI) particles of vesicular stomatitis virus: lack of correlation with content of [+/-] snapback RNA.

Frey TK, Jones EV, Cardamone JJ Jr, Youngner JS.

Virology. 1979 Nov;99(1):95-102. No abstract available.

PMID:
227167
45.
46.

Overview of the activity of a Brucella abortus preparation, Bru-Pel.

Youngner JS, Feingold DS, Keleti G.

Cancer Treat Rep. 1978 Nov;62(11):1915-8.

PMID:
728911
47.

Activation of reticuloendothelial system macrophages and enhancement of host resistance to a transplantable osteogenic sarcoma in mice by an extract of Brucella abortus.

Glasgow LA, Crane JL Jr, Schleupner CJ, Kern ER, Youngner JS, Feingold DS.

Cancer Treat Rep. 1978 Nov;62(11):1931-5.

PMID:
282007
48.

Antitumor activity of interferon against murine osteogenic sarcoma in vitro and in vivo.

Glasgow LA, Crane JL Jr, Kern ER, Youngner JS.

Cancer Treat Rep. 1978 Nov;62(11):1881-8.

PMID:
282006
49.

Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel.

Schultz RM, Chirigos MA, Pavlidis NA, Youngner JS.

Cancer Treat Rep. 1978 Nov;62(11):1937-41.

PMID:
103619
50.

Induction of interferon by temperature-sensitive mutants of Newcastle disease virus.

Kowal KJ, Youngner JS.

Virology. 1978 Oct 1;90(1):90-102. No abstract available.

PMID:
568850

Supplemental Content

Loading ...
Support Center